These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 15734971

  • 1. Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
    Lindblad M, Lagergren J, García Rodríguez LA.
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):444-50. PubMed ID: 15734971
    [Abstract] [Full Text] [Related]

  • 2. Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County.
    Duan L, Wu AH, Sullivan-Halley J, Bernstein L.
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):126-34. PubMed ID: 18187391
    [Abstract] [Full Text] [Related]

  • 3. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
    Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, Chow WH, Dubrow R, Ahsan H, Mayne ST, Schoenberg JB, West AB, Rotterdam H, Fraumeni JF, Blot WJ.
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):97-102. PubMed ID: 9488582
    [Abstract] [Full Text] [Related]

  • 4. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
    Vaughan TL, Farrow DC, Hansten PD, Chow WH, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Rotterdam H, Dubrow R, Ahsan H, West AB, Blot WJ, Fraumeni JF.
    Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):749-56. PubMed ID: 9752982
    [Abstract] [Full Text] [Related]

  • 5. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.
    Bardia A, Ebbert JO, Vierkant RA, Limburg PJ, Anderson K, Wang AH, Olson JE, Vachon CM, Cerhan JR.
    J Natl Cancer Inst; 2007 Jun 06; 99(11):881-9. PubMed ID: 17551148
    [Abstract] [Full Text] [Related]

  • 6. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
    Jacobs EJ, Rodriguez C, Mondul AM, Connell CJ, Henley SJ, Calle EE, Thun MJ.
    J Natl Cancer Inst; 2005 Jul 06; 97(13):975-80. PubMed ID: 15998950
    [Abstract] [Full Text] [Related]

  • 7. Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus.
    Sadeghi S, Bain CJ, Pandeya N, Webb PM, Green AC, Whiteman DC, Australian Cancer Study.
    Cancer Epidemiol Biomarkers Prev; 2008 May 06; 17(5):1169-78. PubMed ID: 18483339
    [Abstract] [Full Text] [Related]

  • 8. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.
    Res Rep Health Eff Inst; 2009 Mar 06; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [Abstract] [Full Text] [Related]

  • 9. Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
    Platz EA, Rohrmann S, Pearson JD, Corrada MM, Watson DJ, De Marzo AM, Landis PK, Metter EJ, Carter HB.
    Cancer Epidemiol Biomarkers Prev; 2005 Feb 06; 14(2):390-6. PubMed ID: 15734963
    [Abstract] [Full Text] [Related]

  • 10. Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer.
    Johnson TW, Anderson KE, Lazovich D, Folsom AR.
    Cancer Epidemiol Biomarkers Prev; 2002 Dec 06; 11(12):1586-91. PubMed ID: 12496048
    [Abstract] [Full Text] [Related]

  • 11. Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study.
    Friis S, Thomassen L, Sørensen HT, Tjønneland A, Overvad K, Cronin-Fenton DP, Vogel U, McLaughlin JK, Blot WJ, Olsen JH.
    Eur J Cancer Prev; 2008 Apr 06; 17(2):88-96. PubMed ID: 18287865
    [Abstract] [Full Text] [Related]

  • 12. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.
    Johnsen SP, Larsson H, Tarone RE, McLaughlin JK, Nørgård B, Friis S, Sørensen HT.
    Arch Intern Med; 2005 May 09; 165(9):978-84. PubMed ID: 15883235
    [Abstract] [Full Text] [Related]

  • 13. Socioeconomic position and the risk of gastric and oesophageal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
    Nagel G, Linseisen J, Boshuizen HC, Pera G, Del Giudice G, Westert GP, Bueno-de-Mesquita HB, Allen NE, Key TJ, Numans ME, Peeters PH, Sieri S, Siman H, Berglund G, Hallmans G, Stenling R, Martinez C, Arriola L, Barricarte A, Chirlaque MD, Quiros JR, Vineis P, Masala G, Palli D, Panico S, Tumino R, Bingham S, Boeing H, Bergmann MM, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Olsen A, Tjonneland A, Trichopoulou A, Bamia C, Soukara S, Sabourin JC, Carneiro F, Slimani N, Jenab M, Norat T, Riboli E, González CA.
    Int J Epidemiol; 2007 Feb 09; 36(1):66-76. PubMed ID: 17227779
    [Abstract] [Full Text] [Related]

  • 14. Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women.
    Reeves MJ, Newcomb PA, Trentham-Dietz A, Storer BE, Remington PL.
    Cancer Epidemiol Biomarkers Prev; 1996 Dec 09; 5(12):955-60. PubMed ID: 8959316
    [Abstract] [Full Text] [Related]

  • 15. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.
    Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A, Women's Health Initiative.
    Cancer Res; 2003 Sep 15; 63(18):6096-101. PubMed ID: 14522941
    [Abstract] [Full Text] [Related]

  • 16. Antacid drug use and risk of esophageal and gastric adenocarcinomas in Los Angeles County.
    Duan L, Wu AH, Sullivan-Halley J, Bernstein L.
    Cancer Epidemiol Biomarkers Prev; 2009 Feb 15; 18(2):526-33. PubMed ID: 19190141
    [Abstract] [Full Text] [Related]

  • 17. Aspirin and nonsteroidal anti-inflammatory drug use and risk of pancreatic cancer: a meta-analysis.
    Larsson SC, Giovannucci E, Bergkvist L, Wolk A.
    Cancer Epidemiol Biomarkers Prev; 2006 Dec 15; 15(12):2561-4. PubMed ID: 17164387
    [Abstract] [Full Text] [Related]

  • 18. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence.
    Anderson LA, Johnston BT, Watson RG, Murphy SJ, Ferguson HR, Comber H, McGuigan J, Reynolds JV, Murray LJ.
    Cancer Res; 2006 May 01; 66(9):4975-82. PubMed ID: 16651456
    [Abstract] [Full Text] [Related]

  • 19. Nonsteroidal anti-inflammatory drugs and the risk of actinic keratoses and squamous cell cancers of the skin.
    Butler GJ, Neale R, Green AC, Pandeya N, Whiteman DC.
    J Am Acad Dermatol; 2005 Dec 01; 53(6):966-72. PubMed ID: 16310056
    [Abstract] [Full Text] [Related]

  • 20. Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis.
    González-Pérez A, García Rodríguez LA, López-Ridaura R.
    BMC Cancer; 2003 Oct 31; 3():28. PubMed ID: 14588079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.